110 related articles for article (PubMed ID: 34029463)
1. Design, Synthesis, and Structure-Activity Relationship of
Chen Z; Zhang L; Yang J; Zheng L; Hu F; Duan S; Nandakumar KS; Liu S; Yin H; Cheng K
J Med Chem; 2021 Jun; 64(11):7371-7389. PubMed ID: 34029463
[TBL] [Abstract][Full Text] [Related]
2. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
[TBL] [Abstract][Full Text] [Related]
3. Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation.
Khan J; Sharma PK; Mukhopadhaya A
Immunobiology; 2015 Nov; 220(11):1199-209. PubMed ID: 26093918
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of 3-(2
Wang Y; Cheng X; Liu X; Xu J; Wang L; Zhang S; Liu S; Peng T
J Med Chem; 2024 Mar; 67(6):4583-4602. PubMed ID: 38498304
[TBL] [Abstract][Full Text] [Related]
5. CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers.
Rapsinski GJ; Newman TN; Oppong GO; van Putten JPM; Tükel Ç
J Biol Chem; 2013 May; 288(20):14178-14188. PubMed ID: 23548899
[TBL] [Abstract][Full Text] [Related]
6. Diabetes increases the susceptibility to acute kidney injury after myocardial infarction through augmented activation of renal Toll-like receptors in rats.
Ohno K; Kuno A; Murase H; Muratsubaki S; Miki T; Tanno M; Yano T; Ishikawa S; Yamashita T; Miura T
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1130-H1142. PubMed ID: 28822965
[TBL] [Abstract][Full Text] [Related]
7. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice.
Wang Y; Su L; Morin MD; Jones BT; Mifune Y; Shi H; Wang KW; Zhan X; Liu A; Wang J; Li X; Tang M; Ludwig S; Hildebrand S; Zhou K; Siegwart DJ; Moresco EMY; Zhang H; Boger DL; Beutler B
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8698-E8706. PubMed ID: 30150374
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis MymA is a TLR2 agonist that activate macrophages and a T
Saraav I; Singh S; Pandey K; Sharma M; Sharma S
Tuberculosis (Edinb); 2017 Sep; 106():16-24. PubMed ID: 28802400
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of urea analogues bearing N-alkyl-N'-(thiophen-2-yl) scaffold and evaluation of their innate immune response to toll-like receptors.
Chen Z; Cen X; Yang J; Lin Z; Liu M; Cheng K
Eur J Med Chem; 2019 May; 169():42-52. PubMed ID: 30852386
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects.
Joseph AM; Srivastava R; Zabaleta J; Davila E
Cancer Immunol Res; 2016 Aug; 4(8):708-16. PubMed ID: 27267778
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic factor VIII does not trigger TLR1.2 and TLR2.6 signalling in vitro.
Teyssandier M; André S; Gupta N; Dasgupta S; Bayry J; Kaveri SV; Lacroix-Desmazes S;
Haemophilia; 2013 May; 19(3):399-402. PubMed ID: 23252683
[TBL] [Abstract][Full Text] [Related]
13. IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function.
Li S; Yao JC; Oetjen KA; Krambs JR; Xia J; Zhang J; Schmidt AP; Helton NM; Fulton RS; Heath SE; Turnbull IR; Mbalaviele G; Ley TJ; Walter MJ; Link DC
Blood; 2022 Oct; 140(14):1607-1620. PubMed ID: 35675516
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationships and preliminary mechanism study of N-benzylideneaniline derivatives as potential TLR2 inhibitors.
Cai S; Zhu G; Cen X; Bi J; Zhang J; Tang X; Chen K; Cheng K
Bioorg Med Chem; 2018 May; 26(8):2041-2050. PubMed ID: 29534935
[TBL] [Abstract][Full Text] [Related]
15. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
Rajalakshmy AR; Malathi J; Madhavan HN
PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
[TBL] [Abstract][Full Text] [Related]
17. The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signalling patterns in human monocytes.
Funderburg NT; Jadlowsky JK; Lederman MM; Feng Z; Weinberg A; Sieg SF
Immunology; 2011 Oct; 134(2):151-60. PubMed ID: 21896010
[TBL] [Abstract][Full Text] [Related]
18. A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens.
Burger-Kentischer A; Abele IS; Finkelmeier D; Wiesmüller KH; Rupp S
J Immunol Methods; 2010 Jun; 358(1-2):93-103. PubMed ID: 20385141
[TBL] [Abstract][Full Text] [Related]
19. The Type II Secretion System of Legionella pneumophila Dampens the MyD88 and Toll-Like Receptor 2 Signaling Pathway in Infected Human Macrophages.
Mallama CA; McCoy-Simandle K; Cianciotto NP
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138020
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia.
Yang H; Wu L; Deng H; Chen Y; Zhou H; Liu M; Wang S; Zheng L; Zhu L; Lv X
J Neuroinflammation; 2020 May; 17(1):154. PubMed ID: 32393298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
